Results 111 to 120 of about 213,015 (316)

Sacubitril/valsartan versus valsartan initiation in patients naïve to renin–angiotensin system inhibitors: Insights from PARAGLIDE‐HF

European Journal of Heart Failure, EarlyView.
Changes in N‐terminal pro‐B‐type natriuretic peptide and assessment of clinical endpoints according to prior exposure to renin–angiotensin system inhibitors in the Pre‐specified substudy of Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE‐HF).
Nina Nouhravesh, Alexander H. Gunn, Derek Cyr, Adrian F. Hernandez, David A. Morrow, Eric J. Velazquez, Jonathan H. Ward, Samiha Sarwat, Kavita Sharma, Kristin M. Williamson, Randall C. Starling, Serge Lepage, Shelley Zieroth, Scott D. Solomon, Robert J. Mentz   +14 more
wiley   +1 more source

Refractory Hypotension after Tourniquet Deflation in a Patient on Chronic Clomipramine Therapy

Indian Journal of Anaesthesia, 2008
Treatment of intraoperative hypotension in a patient on chronic tricyclic antidepressant therapy(TCA) is contro-versial. Evidence based guidelines for the management of psychotropic drugs during perioperative period are lacking.
Pradeep Govil, P. N. Kakar, Atul Kishore Kapoor, Ankit Sharma, Deepak Govil, Deep Arora   +5 more
doaj  

Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community

ESC Heart Failure, EarlyView.
Roberto Pecoits‐Filho, Michelle M.Y. Wong, Monica Moorthy, Debasish Banerjee, Suman Behera, Viviane Calice‐Silva, Mogamat‐Yazied Chothia, Gates B. Colbert, Martha Gulati, Charles A. Herzog, Fadi Jouhra, Edgar V. Lerma, Charu Malik, Kershaw V. Patel, Amina Rakisheva, Giuseppe M.C. Rosano, Priyanka Satish, Henry H.L. Wu, Angela Yee‐Moon Wang   +18 more
wiley   +1 more source

Cardiac rhythm devices in heart failure with reduced ejection fraction – role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt, Wilfried Mullens, Christophe Leclercq, Andrea M. Russo, Gianluigi Savarese, Michael Böhm, Loreena Hill, Koichiro Kinugawa, Naoki Sato, William T. Abraham, Antoni Bayes‐Genis, Alexandre Mebazaa, Giuseppe M.C. Rosano, Shelley Zieroth, Cecilia Linde, Javed Butler   +15 more
wiley   +1 more source

CONTROLLED HYPOTENSION IN THEORY AND PRACTICE

, 1953
J. P. Payne
openalex   +1 more source

Skeletal-Muscle Oxygen Tension and Metabolism During Induced Hypotension and During Vasopressor Administration [PDF]

, 1963
Robert L. Willenkin, Nicholas M. Greene
openalex   +1 more source

Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, rate ratio. Abstract Aims The efficacy and safety of the non‐steroidal mineralocorticoid receptor antagonist, finerenone, have not been examined in patients
Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Carolyn S.P. Lam, Meike Brinker, Patrick Schloemer, Prabhakar Viswanathan, Andrea Lage, Katja Rohwedder, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray   +18 more
wiley   +1 more source

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Carolyn S.P. Lam, Katharina Mueller, Markus F. Scheerer, Prabhakar Viswanathan, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray   +16 more
wiley   +1 more source

Intracranial hypotension

Diagnostic and Interventional Imaging, 2014
Lambert, A., Jacob, D., Hansen, S.
openaire   +2 more sources

An unusual presentation of pheochromocytoma accompanied by catecholamine‐induced cardiomyopathy

ESC Heart Failure, EarlyView.
Hugh O.J. Roberts, Alexandru Munteanu, Jonas E. Mertens   +2 more
wiley   +1 more source